
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Geron typically reports earnings before market open, meaning Day 0 captures the market's immediate reaction in the first trading session, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-06 | -$0.07 (-4.24%) | $0.18 (10.61%) | -$0.12 (-7.59%) | $0.16 (10.44%) |
| 2026-02-25 | -$0.23 (-11.79%) | $0.28 (14.36%) | -$0.07 (-4.07%) | $0.20 (11.63%) |
| 2025-11-05 | -$0.06 (-5.22%) | $0.10 (8.70%) | -$0.01 (-0.92%) | $0.06 (5.50%) |
| 2025-08-06 | +$0.19 (+15.83%) | $0.11 (9.17%) | -$0.09 (-6.47%) | $0.14 (10.07%) |
| 2025-05-07 | -$0.01 (-0.76%) | $0.17 (12.88%) | -$0.05 (-3.82%) | $0.07 (5.34%) |
| 2025-02-26 | -$0.76 (-32.07%) | $0.31 (13.29%) | +$0.13 (+8.07%) | $0.25 (15.53%) |
| 2024-11-07 | +$0.02 (+0.47%) | $0.35 (8.20%) | -$0.04 (-0.93%) | $0.18 (4.20%) |
| 2024-08-08 | +$0.04 (+0.88%) | $0.57 (12.61%) | +$0.10 (+2.17%) | $0.26 (5.54%) |
| Avg Abs Move | 8.91% | 11.22% | 4.26% | 8.53% |
Historical price action around GERN earnings shows significant volatility, with an average absolute Day 0 move of 8.91% and Day +1 move of 4.26%. The most recent earnings on May 6, 2026, saw the stock decline 4.24% on Day 0 despite beating estimates, followed by further weakness. The February 2026 report triggered an 11.79% Day 0 decline, while August 2025 delivered a notable 15.83% Day 0 gain—the strongest positive reaction in the dataset.
The pattern reveals that GERN tends to experience its largest moves immediately on earnings day, with Day +1 typically showing smaller follow-through. Intraday volatility is substantial, with Day 0 trading ranges averaging 11.22%. Investors should prepare for potential double-digit percentage swings, particularly given the stock's recent tendency toward negative reactions despite estimate beats, suggesting the market may be focused on forward guidance or revenue trajectory rather than backward-looking EPS performance.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 17) |
| Expected Move | $0.3060 (22.84%) |
| Expected Range | $1.0340 to $1.6460 |
| Implied Volatility | 334.06% |
The options market is pricing an expected move of 22.84% (±$0.31) through the August 21 expiration, significantly higher than the 8.91% average Day 0 move and 11.22% average Day 0 range observed in recent earnings. This elevated implied volatility suggests options traders are anticipating a more dramatic reaction than historical patterns would indicate, potentially reflecting heightened uncertainty around the company's commercial progress or profitability timeline.
Analyst sentiment on Geron remains mixed, with a consensus rating of 3.71 (between Hold and Buy) based on seven analysts. The breakdown shows 3 Strong Buys, 1 Moderate Buy, 2 Holds, and 1 Strong Sell, reflecting divergent views on the stock's prospects. The average price target of $3.40 implies 154% upside from the current price of $1.34, with estimates ranging from a low of $1.00 to a high of $5.00.
Sentiment has remained unchanged over the past month, with no shifts in the distribution of ratings. This stability suggests analysts are in wait-and-see mode ahead of earnings, likely looking for confirmation that the company's commercial execution can support the aggressive profitability projections embedded in 2027 estimates. The wide dispersion in price targets—from $1.00 to $5.00—underscores the uncertainty around GERN's valuation, with bulls betting on successful commercialization and bears questioning whether the current trajectory justifies the market cap.
The presence of one Strong Sell rating alongside three Strong Buys highlights the polarized nature of the debate, with skeptics likely concerned about competitive pressures and the path to sustained profitability, while optimists see significant value in the company's narrowing losses and revenue growth potential.
Geron's technical setup heading into earnings has deteriorated sharply, with the Barchart Technical Opinion shifting to a 40% Sell signal from a 24% Buy just one week ago and an 8% Sell a month ago. This rapid reversal reflects mounting selling pressure and weakening momentum as the stock approaches its earnings release.
Timeframe Analysis:
Trend Characteristics: The trend is characterized as Weak with Weakest direction, indicating GERN is in a vulnerable technical position with limited support from momentum indicators heading into the earnings event.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $1.3300 | 50-Day MA | $1.3209 |
| 10-Day MA | $1.3860 | 100-Day MA | $1.4281 |
| 20-Day MA | $1.4220 | 200-Day MA | $1.3989 |
At $1.34, GERN is trading above its 5-day moving average of $1.33 and 50-day moving average of $1.32, but below its 10-day ($1.39), 20-day ($1.42), 100-day ($1.43), and 200-day ($1.40) moving averages. This mixed positioning shows the stock has found short-term support but remains under pressure from longer-term resistance levels. The concentration of moving averages in the $1.32-$1.43 range creates a tight technical band, with the stock currently near the lower end. Given the weak technical opinion, deteriorating sentiment across all timeframes, and the stock's position below most key moving averages, the technical setup is cautionary heading into earnings. Investors should be prepared for heightened volatility, particularly given the options market's expectation of a 22.84% move—well above historical norms—which could trigger stops or force position adjustments if the stock breaks below the $1.32 support zone.